Peter Jönsson

The clinical, metabolic and endocrine features and the quality of life in adults with childhood-onset craniopharyngioma compared with adult-onset craniopharyngioma

Pat Kendall‐Taylor, Peter Jönsson, Roger Abs et al. · European Journal of Endocrinology · 2005 · 127 citations · Full text

Medicine, Endocrinology, Oncology +9

Changes in Height, Weight, and Body Mass Index in Children with Craniopharyngioma after Three Years of Growth Hormone Therapy: Analysis of KIGS (Pfizer International Growth Database)

Mitchell E. Geffner, Michael Lundberg, Maria Kołtowska‐Häggström et al. · The Journal of Clinical Endocrinology & Metabolism · 2004 · 95 citations

Medicine, Oncology, Pediatrics +15

Long-Term Treatment with Pegvisomant as Monotherapy in Patients with Acromegaly: Experience from Acrostudy

Pamela U. Freda, Murray B. Gordon, Nicky Kelepouris et al. · Endocrine Practice · 2014 · 89 citations

Pharmacy, Endocrinology, Pharmacotherapy +4

Long-term treatment with pegvisomant: observations from 2090 acromegaly patients in ACROSTUDY

Michael Buchfelder, Aart‐Jan van der Lely, Beverly M. K. Biller et al. · European Journal of Endocrinology · 2018 · 89 citations · Full text

Medicine, Endocrinology, Pharmacotherapy +16

Baseline Characteristics and Response to 2 Years of Growth Hormone (GH) Replacement of Hypopituitary Patients with GH Deficiency due to Adult-Onset Craniopharyngioma in Comparison with Patients with Nonfunctioning Pituitary Adenoma: Data from KIMS (Pfizer International Metabolic Database)

Johan Verhelst, Pat Kendall‐Taylor, Eva Marie Erfurth et al. · The Journal of Clinical Endocrinology & Metabolism · 2005 · 72 citations · Full text

Medicine, Endocrinology, Oncology +17